TrialPath

Find a study

Browse recruiting studies near you — free to check, always your choice.

Match me to a study

46 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

  • High blood pressureKidney disease

    📍 Research Site · Surprise, AZ · +17 more US sites · Get directions →

    International, Multicenter and Double-Blind study. The purpose is to measure the effect of baxdrostat in combination with dapagliflozin compared with baxdrostat/placebo on albuminuria, as well as safety, in participants with chronic kidney disease and high blood pressure.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Type 2 diabetesHigh blood pressure

    Polypill for Prevention of Cardiomyopathy

    Testing a pill combination to prevent heart muscle disease in people with type 2 diabetes and high

    📍 UT Southwestern Medical Center · Dallas, TX · Get directions →

    This study will investigate the utility of a polypill-based strategy for patients with type 2 diabetes mellitus and high risk of heart failure (HF), as assessed via the WATCH-DM risk score. Polypill therapy will consist of empagliflozin 12.5 mg, losartan 25, 50 or 100 mg, and finerenone 10 mg daily.

    ✓ Study care freePhase 1Ages 18–100Learn more →
  • High blood pressure

    Arterial Ablation for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities

    Testing a device used through a blood-vessel procedure for type 2 diabetes and high blood pressure

    💵 May compensate

    📍 Hospital Paitilla Clinicas y Hospitales · Panama City, · Get directions →

    This study is assess the safety and performance of the Neurotronic Infusion catheter for treatment of patients with Type 2 Diabetes (T2DM) and hypertension.

    ✓ Study care freePhase 1Ages 21–65Learn more →
  • Rheumatoid arthritis

    Dynamic Treatment Regiments for Glucocorticoid Tapering

    Studying how people with rheumatoid arthritis respond to tapering steroid medicine

    📍 VA Ann Arbor Healthcare System, Ann Arbor, MI · Ann Arbor, MI · +1 more US site · Get directions →

    The purpose of this clinical trial is to better understand how people with rheumatoid arthritis (RA) respond to gradual dose reduction, or "tapering", of steroid medications like prednisone. Some people with RA have symptoms when steroid dose is reduced, while others don't.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Obesity / overweightHigh blood pressure

    A Study of LY3971297 in Healthy Participants

    Testing side effects and how the body processes an injection in healthy and obese people with high

    📍 CenExel ACT · Anaheim, CA · +2 more US sites · Get directions →

    The purpose of this study is to measure side effects of LY3971297 injection administered under the skin in healthy participants and obese participants with high blood pressure (BP). Blood tests will be performed to check how much LY3971297 gets into the bloodstream and how long it takes the body to eliminate it.

    ✓ Study care freePhase 1Ages 18–75Learn more →
  • Lupus (SLE)Rheumatoid arthritis

    A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)

    Testing a CD19-targeted CAR T cell treatment in people with severe lupus or rheumatoid arthritis

    📍 University of Colorado Anschutz Medical Campus · Aurora, CO · +30 more US sites · Get directions →

    The purpose of this study is to establish the tolerability, preliminary efficacy, and pharmacokinetics of CC-97540 in participants with severe, refractory autoimmune diseases (Breakfree-1).

    ✓ Study care freePhase 1Ages 18+Learn more →
  • Rheumatoid arthritis

    📍 Artiva Investigational Site Tuscaloosa · Tuscaloosa, AL · +30 more US sites · Get directions →

    A Basket Trial of Refractory Rheumatoid Arthritis (RA), Sjögren's Disease (SjD), Idiopathic Inflammatory Myopathies (IIMs) and Systemic Sclerosis (SSc) subjects to evaluate the safety and efficacy of AlloNK, a non-genetically modified allogeneic NK cell, in combination with rituximab.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Rheumatoid arthritis

    📍 Arizona Arthritis & Rheumatology Associates · Gilbert, AZ · +21 more US sites · Get directions →

    This is a Phase 2 randomized, double-blind, placebo-controlled study with a total duration of 32 weeks from Screening to End-of-Study (EOS) Visit. Approximately 180 participants are planned to be enrolled.

    ✓ Study care freePhase 2Ages 18–75Learn more →
  • Rheumatoid arthritis

    A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

    Testing how safe and tolerable an immune-cell treatment is for rheumatoid arthritis

    📍 Nkarta Investigational Site · Orange, CA · +14 more US sites · Get directions →

    This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized dose escalation and dose expansion basket study to determine the safety and tolerability of NKX019 (allogeneic CAR NK cells targeting CD19) in participants with autoimmune diseases.

    ✓ Study care freePhase 1Ages 18–75Learn more →
  • High blood pressureCOPD (chronic lung disease)

    Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

    Testing tadalafil to see if it improves shortness of breath in COPD with high blood pressure in the

    📍 Rocky Mountain Regional VA Medical Center, Aurora, CO · Aurora, CO · +4 more US sites · Get directions →

    The investigators will study whether the drug tadalafil improves shortness of breath in 126 Veterans with Chronic Obstructive Pulmonary Disease (COPD) and high blood pressure in the lungs. The investigators will also assess whether tadalafil improves quality of life, home daily physical activity, exercise endurance, the frequency of acute flares of COPD, blood pressure in the lungs, and lung function.

    ✓ Study care freePhase 2Ages 35–89Learn more →
  • Rheumatoid arthritis

    Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis

    Testing how a single dose works and whether it is safe in people with rheumatoid arthritis

    📍 Mayo Clinic · Scottsdale, AZ · +8 more US sites · Get directions →

    This study will test the safety and effects of SBT777101 when given as a single dose to subjects with rheumatoid arthritis. It is the first study of this treatment being done in humans.

    ✓ Study care freePhase 1Ages 18–70Learn more →
  • Rheumatoid arthritis

    Study of GS-0151 in Participants With Rheumatoid Arthritis

    Testing a study drug in people with rheumatoid arthritis to assess safety

    📍 Pinnacle Research Group, LLC · Anniston, AL · +17 more US sites · Get directions →

    The goal of this clinical study is to learn more about the study drug GS-0151. The study is done to find how safe, well-tolerated the drug is.

    ✓ Study care freePhase 1Ages 18–75Learn more →
  • Rheumatoid arthritis

    "Effect of Vitamin E (α-Tocopherol) on Clinical Activity and Inflammation in Rheumatoid Arthritis"

    Testing whether vitamin E lowers inflammation and symptoms in rheumatoid arthritis

    📍 Civil Hospital of Guadalajara · Guadalajara, Jalisco · Get directions →

    The objective of this clinical trial is to determine whether α-tocopherol (vitamin E) supplementation decreases inflammation and clinical activity in patients with rheumatoid arthritis (RA).The main questions to be answered are: * Is supplementation with vitamin E (α-tocopherol) for one month associated with decreased clinical activity and inflammation in patients with RA? Researchers will compare α-tocopherol with a placebo (a look-alike substance containing no active ingredient) to see if α-tocopherol effectively reduces inflammation and clinical activity in patients with rheumatoid arthritis.

    ✓ Study care freePhase 2Ages 18+WomenLearn more →
  • Obesity / overweightHigh blood pressure

    Mitigating the Pro-inflammatory Phenotype of Obesity

    Testing whether 4 weeks of a blood pressure medicine can reduce inflammation in people with obesity

    📍 University of Kansas Medical Center · Kansas City, KS · Get directions →

    The purpose of this study is to examine the hypothesize that 4 weeks of sympathetic nerve activity (SNA) inhibition (oral clonidine) will cause a significant reduction in circulating blood concentrations and endothelial cell expression of inflammatory markers (e.g., TNF-α, IL-6). Our study is a prospective study using a randomized, double-blinded design to test 4 weeks of SNA blockade (oral clonidine) compared with a BP-lowering control condition (diuretic, hydrochlorothiazide) or a placebo.

    ✓ Study care freePhase 1Ages 18–79Learn more →
  • Obesity / overweightHigh blood pressure

    Cardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension

    Testing whether angiotensin-(1-7) affects heart health in people with obesity and high blood

    📍 Penn State Milton S. Hershey Medical Center · Hershey, PA · Get directions →

    Obesity is a global health concern that is associated with high blood pressure and an increased risk for developing cardiovascular disease. The purpose of this study is to find out if the investigational drug angiotensin-(1-7) can improve cardiovascular health in people with obesity and high blood pressure.

    ✓ Study care freeEarly Phase 1Ages 18–65Learn more →
  • Rheumatoid arthritis

    Imaging of Lymphatic Vessels in People With Rheumatoid Arthritis (RA)

    Testing ways to see lymph vessels in people with rheumatoid arthritis

    📍 University of Rochester · Rochester, NY · Get directions →

    Lymphatic transport was previously examined by these investigators using Near InfraRed Indocyanine Green fluorescence imaging (NIR-ICG) of the upper extremities. They established reliable and reproducible methodologies in RA patients.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • Rheumatoid arthritis

    A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

    Testing targeted treatments for people with moderate to severe rheumatoid arthritis

    📍 Sun Valley Arthritis Center /ID# 278331 · Peoria, AZ · +39 more US sites · Get directions →

    Rheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, swelling and loss of joint function. This study will evaluate the efficacy and safety of targeted therapies through a series of substudies for the treatment of moderately to severely active Rheumatoid Arthritis (RA).

    ✓ Study care freePhase 2Ages 18+Learn more →
  • High blood pressureDementia / Alzheimer's

    Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)

    Testing whether tightly lowering high blood pressure slows brain changes tied to Alzheimer’s

    📍 University of Texas Southwestern Medical Center · Dallas, TX · Get directions →

    The purpose of this study is to determine if intensive lowering of systolic blood pressure (SBP), using FDA approved medications (antihypertensive), reduces Alzheimer's Disease pathology (i.e., excessive brain amyloid and tau protein deposition) in older adults at high risk for memory decline or dementia.

    ✓ Study care freePhase 2Ages 60–85Learn more →
  • Rheumatoid arthritis

    A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis

    Testing how a treatment called LY4213663 is tolerated and side effects in people with rheumatoid

    📍 Pinnacle Research Group, LLC · Anniston, AL · +8 more US sites · Get directions →

    The purpose of this study is to evaluate how well LY4213663 is tolerated and what side effects may occur in healthy participants and participants with rheumatoid arthritis (RA). The study drug will be administered either subcutaneously (SC) (under the skin) or intravenously (IV) (into a vein in the arm).

    ✓ Study care freePhase 1Ages 18–75Learn more →
  • Rheumatoid arthritis

    A Study of AZD0120 in Autoimmune Diseases

    Testing safety of a gene-cell treatment in adults with hard-to-treat rheumatoid arthritis

    📍 Research Site · Tucson, AZ · +7 more US sites · Get directions →

    This trial is a Phase 1b, open-label, multi-center, clinical study of AZD0120, a BCMA/CD19 dual targeting CAR+ T-cell therapy, to evaluate the safety and tolerability in adult participants with systemic sclerosis (SSc), idiopathic inflammatory myopathies (IIM), or difficult-to-treat rheumatoid arthritis (D2T RA).

    ✓ Study care freePhase 1Ages 18–75Learn more →
  • Lupus (SLE)Rheumatoid arthritisCrohn's / ulcerative colitis (IBD)

    COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

    Testing COVID-19 booster and flu vaccine schedules in people with lupus, rheumatoid arthritis, or

    📍 Maisonneuve -Rosemont Installation · Montreal, Quebec · Get directions →

    The goal of this pragmatic embedded open-label, 2 x 2 factorial phase II randomized controlled trial is to evaluate strategies to improve COVID-19 booster and influenza vaccine immunogenicity in people living with immunocompromising conditions (PLIC). The main questions it aims to answer are: 1.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Obesity / overweightHigh blood pressureCOPD (chronic lung disease)

    Feasibility of Semaglutide in Advanced Lung Disease

    Testing whether semaglutide can be given safely to people with advanced lung disease

    📍 University of Pennsylvania Perelman School of Medicine · Philadelphia, PA · Get directions →

    The goal of this clinical trial is to learn whether semaglutide, an FDA-approved treatment for diabetes and obesity, is feasible and tolerable in patients with advanced lung disease. The main question\[s\] it aims to answer are: 1.

    ✓ Study care freePhase 1Ages 18–80Learn more →
  • Lupus (SLE)Rheumatoid arthritis

    📍 Pinnacle Research Group /ID# 278677 · Anniston, AL · +9 more US sites · Get directions →

    Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease characterized by B cell hyperactivity. Rheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, swelling and loss of joint function.

    ✓ Study care freePhase 1Ages 18–75Learn more →
  • Rheumatoid arthritis

    An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis

    Testing the long-term safety and results of afimkibart in rheumatoid arthritis

    📍 DM Clinical Research · Tomball, TX · Get directions →

    The study will evaluate the long-term safety and efficacy of Afimkibart (also known as RO7790121) in participants with moderate to severe Rheumatoid Arthritis (RA) who have an inadequate response or intolerance to tumor necrosis factor (TNF) and/or Janus kinase (JAK) inhibitors, and who were previously treated with Afimkibart.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Rheumatoid arthritis

    📍 SunValley Arthritis Center Ltd. · Peoria, AZ · +11 more US sites · Get directions →

    This study will assess the efficacy and safety of Afimkibart (also known as RO7790121) compared with placebo in participants with moderate to severe rheumatoid arthritis (RA) who have an inadequate response or intolerance to TNF and/or JAK inhibitors.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Lupus (SLE)Rheumatoid arthritis

    A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)

    Testing a study medicine for safety in people with lupus or rheumatoid arthritis

    📍 Gold Coast University Hospital ( Site 1601) · Southport, Queensland · Get directions →

    This study looks at a study medicine called MK-1045 in people with lupus and rheumatoid arthritis (RA). The main goal of the study is to learn about the safety of MK-1045 and if people tolerate it when they receive it at different dose levels (amounts).

    ✓ Study care freePhase 1Ages 18–75Learn more →
  • Lupus (SLE)Rheumatoid arthritis

    A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

    Testing how safe inebilizumab and blinatumomab are in adults with lupus or rheumatoid arthritis

    📍 HonorHealth Research and Innovation Institute · Scottsdale, AZ · +16 more US sites · Get directions →

    The main objective is to assess the safety and tolerability of inebilizumab in adult participants with active and refractory systemic lupus erythematosus (SLE) with nephritis (Subprotocol A) and to assess the safety and tolerability of subcutaneous (SC) blinatumomab in adult participants with active and refractory SLE with and without nephritis (Subprotocol B Part A) and in adult participants with active refractory rheumatoid arthritis (RA) (Subprotocol C Part A). The trial will also assess the efficacy of SC blinatumomab in adult participants with active and refractory SLE with and without nephritis (Subprotocol B Part B and Subprotocol C Part B).

    ✓ Study care freePhase 2Ages 18–75Learn more →
  • Lupus (SLE)Rheumatoid arthritis

    Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.

    Testing safety and effects of AB-101 with rituximab in lupus and rheumatoid arthritis

    📍 IRIS Research and Development, LLC · Plantation, FL · Get directions →

    This study will evaluate the safety and activity of AB-101 in combination with rituximab in B-cell associated autoimmune diseases where rituximab is currently FDA approved (e.g., Rheumatoid Arthritis (RA), Pemphigus Vulgaris (PV), Granulomatosis with polyangiitis (GPA)/microscopic polyangiitis (MPA) as a therapeutic, or is recommended (e.g., in Systemic Lupus Erythematosus (SLE) as a cornerstone for disease management.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • High blood pressureKidney disease

    Equol and Vascular Function in Women With Chronic Kidney Disease

    Testing whether equol affects blood vessel function in women with chronic kidney disease

    📍 University of Colorado Anschutz Medical Campus · Aurora, CO · Get directions →

    The risk of cardiovascular disease (CVD) is significantly elevated in patients with chronic kidney disease (CKD). Notably, women with CKD commonly experience menstrual disturbances induced by CKD, which may contribute to impaired vascular function and elevated CVD risk.

    ✓ Study care freePhase 2Ages 50+WomenLearn more →
  • Lupus (SLE)Rheumatoid arthritis

    Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

    Testing the safety and side effects of surovatamig in adults with RA or lupus

    📍 Research Site · Birmingham, AL · +4 more US sites · Get directions →

    This open-label, Phase I study will assess the safety and tolerability of surovatamig and characterise its PK and PD following subcutaneous administration to participants with RA or SLE.

    ✓ Study care freePhase 1Ages 18–65Learn more →
  • Obesity / overweightHigh blood pressure

    Understanding the Health Effect of a Bioactive Peptide From Egg: A Pilot Study

    Testing how an egg-derived peptide affects health in people with obesity and high blood pressure

    📍 University of Alberta · Edmonton, Alberta · Get directions →

    Bioactive peptides derived from food proteins show potential for improving human health. One of such promising peptides is namely IRW made from egg white hydrolysate and composed of three peptides.

    ✓ Study care freePhase 1Ages 18–70Learn more →
  • Rheumatoid arthritis

    📍 Nouvelle Clinical Research LLC · Cutler Bay, FL · +2 more US sites · Get directions →

    The study is a randomized, double blind, placebo-controlled, dose response, phase II, multicentre trial to evaluate the efficacy and safety of oral AP1189 administered at the doses of 40, 70, or 100 mg for 12 weeks in combination with methotrexate, in DMARD-naïve participants with early rheumatoid arthritis and active inflammation.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Rheumatoid arthritis

    A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

    Testing how well and how safely AZD1163 works for people with rheumatoid arthritis

    📍 Research Site · Glendale, AZ · +27 more US sites · Get directions →

    Phase II study in participants with moderately-to-severely active rheumatoid Arthritis (RA) to evaluate efficacy and safety of AZD1163.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Rheumatoid arthritis

    MAD Study of IA-14069

    Testing the safety and dose effects of an oral medicine in healthy people and people with rheumatoid

    📍 ICON plc. · Lenexa, KS · Get directions →

    The purpose of this study is to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple ascending oral doses of IA-14069 in healthy subjects and in patients with RA on stable dosese of MTX, with preliminary assessment of efficacy in RA patients.

    ✓ Study care freePhase 1Ages 18–70Learn more →
  • Rheumatoid arthritis

    Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

    Testing reduced-intensity transplant approaches for people with rheumatoid arthritis

    📍 UPMC Children's Hospital of Pittsburgh · Pittsburgh, PA · Get directions →

    The objective of this study is to evaluate the efficacy of using a reduced-intensity condition (RIC) regimen with umbilical cord blood transplant (UCBT), double cord UCBT, matched unrelated donor (MUD) bone marrow transplant (BMT) or peripheral blood stem cell transplant (PBSCT) in patients with non-malignant disorders that are amenable to treatment with hematopoietic stem cell transplant (HSCT). After transplant, subjects will be followed for late effects and for ongoing graft success.

    ✓ Study care freePhase 2Learn more →
  • Obesity / overweightHeart / cardiovascular diseaseHigh blood pressure

    Metabolic Effects of Angiotensin-(1-7)

    Testing how angiotensin-(1-7) affects body metabolism in obesity

    📍 Vanderbilt University Medical Center · Nashville, TN · Get directions →

    The overall purpose of this study is to learn more about the metabolic effects of angiotensin-(1-7) in the insulin resistant state associated with obesity. Pharmacologic approaches to increase angiotensin-(1-7) levels or its actions are currently in development for treatment of metabolic-related diseases such as obesity and type II diabetes, based on findings from animal studies.

    ✓ Study care freePhase 1Ages 18–60Learn more →
  • Heart / cardiovascular diseaseHigh blood pressureCOPD (chronic lung disease)

    : Vascular Function in Health and Disease

    Studying how blood vessel function works in health and diseases like heart problems, high blood

    📍 George E Wahlen VA Medical Center · Salt Lake City, UT · Get directions →

    Many control mechanisms exist which successfully match the supply of blood with the metabolic demand of various tissues under wide-ranging conditions. One primary regulator of vasomotion and thus perfusion to the muscle tissue is the host of chemical factors originating from the vascular endothelium and the muscle tissue, which collectively sets the level of vascular tone.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • Lupus (SLE)Rheumatoid arthritisMultiple sclerosis (MS)

    Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    Testing nivolumab for side effects and cancer response in people with advanced cancer and autoimmune

    📍 University of Alabama at Birmingham Cancer Center · Birmingham, AL · +39 more US sites · Get directions →

    This phase Ib trial studies the side effects of nivolumab and to see how well it works alone and in combination with other treatments, such as ipilimumab, cabozantinib, platinum containing therapy, and fluoropyrimidine, in treating patients with autoimmune disorders and cancer that has spread from where it first started (primary site) to nearby tissue, lymph nodes, or distant parts of the body (advanced), to other places in the body (metastatic) or cannot removed by surgery (unresectable). Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • High blood pressureCOPD (chronic lung disease)Asthma

    Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

    Testing a lung scan method using hyperpolarized oxygen gas MRI in healthy and people with COPD or

    📍 University of Kansas Medical Center · Kansas City, KS · Get directions →

    The purpose of this study is to develop and evaluate the usefulness of hyperpolarized (HP) 129Xe gas MRI for regional assessment of pulmonary function.

    ✓ Study care freePhase 1Ages 3+Learn more →
  • Heart / cardiovascular diseaseHigh blood pressure

    Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

    Studying how vitamin C affects blood vessel function in obese adults with insulin resistance and

    📍 University of Kansas Medical Center · Kansas City, KS · Get directions →

    The main purpose of research is to examine and understanding the development of hypertension in obese adults with insulin resistance. Findings from our studies will identify unique mechanisms that can be targeted to limit increases in vascular dysfunction and reduce the excessively high prevalence of hypertension and risk for cardiovascular disease (CVD).

    ✓ Study care freePhase 1Ages 35–65Learn more →
  • High blood pressureCOPD (chronic lung disease)

    Pulmonary Hypertension SOLAR

    Testing a noninvasive MRI pattern to study lung blood vessel changes in pulmonary hypertension

    📍 Duke University Medical Center · Durham, NC · Get directions →

    The main goal of this study is to develop a noninvasive signature for pulmonary vascular remodeling in Group 3 PH patients, using hyperpolarized 129Xe magnetic resonance imaging (129Xe MRI). Such a signature may identify Group 3 PH responders to PAH-specific therapies.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Obesity / overweightHigh blood pressure

    Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)

    Studying how the nervous system controls blood pressure in obesity and high blood pressure

    📍 University of Texas Southwestern Medical Center · Dallas, TX · Get directions →

    The purpose of this study is to understand how the nervous system communicates to blood vessels to increase blood pressure during stress. The study will also investigate how hypertension and obesity influence the nervous system and vascular function.

    ✓ Study care freeEarly Phase 1Ages 18–55Learn more →
  • Obesity / overweightHeart / cardiovascular diseaseHigh blood pressure

    PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis

    Testing timing of blood pressure medicines in people with obesity and high blood pressure

    📍 University of Alabama at Birmingham · Birmingham, AL · Get directions →

    Obese individuals have a higher prevalence of nocturnal hypertension and non-dipping blood pressure (BP). These conditions are associated with an increased risk of cardiovascular (CV) events and death.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Rheumatoid arthritis

    Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for RA

    Testing whether an IV infusion of donor stem cells is safe for rheumatoid arthritis

    📍 Medical Surgical Associates Center · St John's, · Get directions →

    This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Rheumatoid Arthritis

    ✓ Study care freePhase 1Learn more →
  • Obesity / overweightHigh blood pressure

    Sympathetic Mechanisms in Obesity-Crossover Design

    Testing whether blocking sympathetic nerves after 2 weeks changes blood sugar in obese adults with

    📍 Vanderbilt University Medical Center · Nashville, TN · Get directions →

    We will study obese hypertensive subjects in a randomized, crossover study to determine if two weeks sympathetic blockade improves endogenous glucose production. Subjects will be studied on 3 different occasions after two weeks of receiving either placebo, amlodipine (vasodilator arm) or moxonidine (study arm).

    ✓ Study care freePhase 1Ages 18–65Learn more →
  • Lupus (SLE)Rheumatoid arthritis

    📍 Research Site · Anniston, AL · +6 more US sites · Get directions →

    The purpose of this study is to measure the safety, tolerability, PK, and PD of AZD5492 administered subcutaneously in adult participants with SLE or IIM or RA Study details include: • The study duration will be a minimum of 180 days in addition to the screening period. Additional follow-up visits may be required up to 12 months from study start.

    ✓ Study care freePhase 1Ages 18–70Learn more →